BMY vs POST · P/E 17, rev $48.19B vs P/E 15, rev $8.16B
Bristol-Myers Squibb Company (BMY) versus Post Holdings Inc (POST) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Post Holdings Inc (POST) is a packaged foods company listed on NYSE.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported POST revenue for 2025-09-30 was $8.16B. Net income was $335.8M. Revenue was up 3.0% from 2024-09-30 to 2025-09-30. POST currently screens at market cap $4.03B and trailing P/E 14.9.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. POST currently screens at market cap $4.03B and trailing P/E 14.9.
Not investment advice. Open the BMY and POST stock pages for the full models.
Not investment advice.